Subscribe To
Enphase energy stock just reminded investors of this timeless lesson
A stock's price reflects investor expectations. A premium valuation implies the company is experiencing fast growth....
August 14, 2023, 7:45 am
Capitalizing on inflammation's role in neurological disease part 1: coya therapeutics
Coya Therapeutics is developing Treg-enhancing therapeutics to target diseases driven by inflammation, including in the central nervous system, includ...
August 14, 2023, 5:45 am
Usdcad daily analysis – august 14, 2023
Currently, the USDCAD currency pair is exhibiting a sideways movement, trading within a range between 1.3371 and 1.3501. This consolidation ...
August 14, 2023, 5:06 am
Roquefort files to patent anti-cancer therapeutics globally
Roquefort Therapeutics PLC (LSE:ROQ, OTCQB:ROQAF) has announced the successful filing of a global patent for its anti-cancer therapeutics. Once approv...
August 14, 2023, 3:56 am
Helium one achieves significant milestones ahead of tanzania drilling next month
Helium One Global Ltd (AIM:HE1, OTCQB:HLOGF) has announced significant progress at its Rukwa project site, in Tanzania, paving the way for the ...
August 14, 2023, 3:29 am
Pds biotechnology: interim data reinforces push towards phase 3 study
PDS Biotechnology has achieved positive results in its phase 2 study of PDS0101 in combination with Mer...
August 14, 2023, 12:22 am
Xenon is well-funded heading into key readouts
Xenon Pharmaceuticals has a strong cash position of $652.2M and an estimated cash runway of approximately 3.11 years. The company's financial health i...
August 13, 2023, 9:20 am
Perdoceo education: learning how to make online money, for the long run
After a long phase of business model transformation, Perdoceo Education's fundamentals appear attractiv...
August 13, 2023, 2:01 am
Prophase labs, inc. (prph) q2 2023 earnings call transcript
Prophase Labs, Inc. (NASDAQ:PRPH ) Q2 2023 Earnings Conference Call August 10, 2023 11:00 AM ET Company...
August 12, 2023, 11:04 am
Jasper therapeutics reports second quarter 2023 financial results and provides a business update
First Patient Dosed in phase 1 trial of Briquilimab in Lower-Risk Myelodysplastic Syndrome Strengthened...
August 11, 2023, 8:05 pm
Kineta reports second quarter 2023 financial results and provides corporate update
Initial Clinical Data Readout from Ongoing phase 1/2 Study of VISTA-Targeting KVA12123 in Advanced Soli...
August 11, 2023, 8:01 pm
Ipo update: adlai nortye readies $72 million u.s. ipo
Adlai Nortye Ltd. has filed for a $72 million IPO for its cancer drug development. The firm's lead candidate, AN2025, is in ...
August 11, 2023, 2:16 pm
Frontera says it will evaluate guyana oil discovery before proceeding
Frontera Energy and its unit CGX Energy expect to complete an analysis in the next two to three months of the Wei-1 oil well in Guyana before deciding...
August 11, 2023, 12:52 pm
Pliant therapeutics: promising phase 2a bexotegrast data unveiled
Pliant Therapeutics is a biotech company focused on developing therapies for fibrotic diseases. The company's financials show an increase in R&D and a...
August 11, 2023, 12:19 pm
Perspective therapeutics announces first patient dosed in phase 1/2a dose escalation trial of vmt01 of its targeted alpha-particle therapy (tat), for treatment of mc1r-positive metastatic melanoma
First patient with MC1R–positive metastatic melanoma treated with 212Pb–VMT01 Preliminary data readout from dose escalation study expected Q4 2023...
August 11, 2023, 12:05 pm
Perspective therapeutics reports second quarter fiscal 2023 results and recent business highlights
phase I/2a clinical trials initiated: VMT-α-NET for neuroendocrine tumors, and VMT01 for melanoma. Pre...
August 11, 2023, 12:00 pm
Enphase's (enph) product demand augments in south carolina
Enphase's (ENPH) Energy System demand, powered by IQ8 Microinverters, increases in South Carolina....
August 11, 2023, 11:32 am
Akero therapeutics reports second quarter 2023 financial results and provides business update
— Positive Results from phase 2b SYMMETRY Cohort D, an expansion cohort of Type 2 diabetic, pre-cirrh...
August 11, 2023, 10:00 am
Aud/usd outlook: rba sees end of inflation woes
The RBA noted that the worst phase of inflation had passed. After reaching a high of 7.8% last year, Au...
August 11, 2023, 9:25 am
Prophase labs announces updated conference call dial-in information for thursday august 10, 2023 at 11:00 a.m. eastern time for second quarter 2023 financial results call.
Garden City, NY, Aug. 10, 2023 (GLOBE NEWSWIRE) — Prophase Labs, Inc. (NASDAQ: PRPH) Conference Call ...
August 10, 2023, 2:40 pm